Abstract:Intracranial atherosclerotic stenosis (ICAS) is one of the most common causes of stroke worldwide, in particular in Chinese, Black and Hispanic populations compared with Caucasians [ 1 Wong L.K. Global burden of intracranial atherosclerosis. Int. J. Stroke. 2006; 1: 158-159 Crossref PubMed Scopus (445) Google Scholar , 2 Gorelick P.B. Wong K.S. Bae H.J. Pandey D.K. Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke. 2008; 39: 2396-2399 Crossref PubMed Scopus (518) Google Scholar ]. In addition to the medical therapy, angioplasty and stenting are alterative surgical approaches. However, recent AHA/ASA guideline on stroke prevention recommended not to adopt stenting with the Wingspan stent system as an initial treatment for patients with stroke or transient ischemic attack attributable to severe (70%–99%) ICAS (class III, level C) [ [3] Kernan W.N. Ovbiagele B. Black H.R. Bravata D.M. Chimowitz M.I. Ezekowitz M.D. et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014; 45: 2160-2236 Crossref PubMed Scopus (3181) Google Scholar ]. This recommendation was formulated based on the only randomized clinical trial — Stenting and Aggressive Medical Management for Prevention Recurrent Stroke and Intracranial Stenosis (SAMMPRIS) trial, which demonstrated that stenting had higher risk for 30-day and long-term stroke and death than aggressive medical therapy in patients with severe ICAS [ 4 Chimowitz M.I. Lynn M.J. Derdeyn C.P. Turan T.N. Fiorella D. Lane B.F. et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N. Engl. J. Med. 2011; 365: 993-1003 Crossref PubMed Scopus (1397) Google Scholar , 5 Derdeyn C.P. Chimowitz M.I. Lynn M.J. Fiorella D. Turan T.N. Janis L.S. et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet. 2014; 383: 333-341 Abstract Full Text Full Text PDF PubMed Scopus (576) Google Scholar ]. However, this trial was performed in Caucasians [ [4] Chimowitz M.I. Lynn M.J. Derdeyn C.P. Turan T.N. Fiorella D. Lane B.F. et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N. Engl. J. Med. 2011; 365: 993-1003 Crossref PubMed Scopus (1397) Google Scholar ]. Asians have more ICAS, and more diffuse lesions, whether the SAMMPRIS result validate in Chinese patients, also needs further investigation.

Intravascular Treatment for Symptomatic Intracranial Atherosclerotic Disease

Endovascular Treatment for Acute Large Vessel Occlusion Due to Underlying Intracranial Atherosclerotic Disease

Diagnosis and treatment of intracranial aneurysm presenting with cerebral ischemia

The Safety and Long-Term Outcomes of Angioplasty and Stenting in Symptomatic Intracranial Atherosclerotic Stenosis

Endovascular Treatment of Intracranial Atherosclerotic Stenosis: Current Debates and Future Prospects

Angioplasty And stenting For symptomatic intracranial atherosclerotic disease: How I Do It

Intracranial atherosclerotic disease

A retrospective study of individualized endovascular treatment for symptomatic intracranial atherosclerotic stenosis in patients with ischemic stroke/transient ischemic attack

Interventional Endovascular Treatment of Intracranial Stenosis

Drug-Coated Balloons for the Treatment of Symptomatic Intracranial High-Grade Stenosis: A Review of the Current Rationale

Clinical Study of Endovascular Stenting for Intracranial Artery Stenosis

Endovascular Stent-Assisted Angioplasty of Symptomatic Intracranial Stenosis

Intracranial atherosclerosis update for neurointerventionalists

Clinical research on treatment of symptomatic intracranial arterial stenosis with Wingspan stent

Efficacy and safety of drug-eluting stent for the intracranial atherosclerotic disease: A systematic review and meta-analysis

Update in the treatment of intracranial atherosclerotic disease

Safety and Efficacy of Intravascular Ultrasound As an Adjunct to Stenting for Cerebral Venous Sinus Stenosis-Induced Idiopathic Intracranial Hypertension: a Pilot Study

Medical Treatment of Intracranial Atherosclerosis: An Update

Experimental and Clinical Advance of Intravascular Stent in Treating Complex Intracranial Aneurysm

Wingspan Stenting for Symptomatic Severe In-Stent Stenosis of a Closed-Cell Stent after Stent-Assisted Coiling of a Ruptured Intracranial Aneurysm

Effect of Drug-Coated Balloon Versus Stent Angioplasty in Patients With Symptomatic Intracranial Atherosclerotic Stenosis